You know that feeling when you see a poster, a thread that just catches your eye?

And you're like, what?

That's what happened to our colleague, Ralph Winkler, this spring.

Here's what he saw.

It's titled Adderall for All.

The post was anonymous, written by someone who said they'd worked at a startup called

Cerebral. Cerebral launched in 2020 with a mission to transform mental health care in

America. And it took off, signing up thousands of patients and securing hundreds of millions

of dollars from Silicon Valley investors.

But the post-Rolf stumbled upon, raised a lot of questions.

It said, you have to be really comfortable prescribing stimulants. Almost all your patients

will want Adderall. And if you don't prescribe a stimulant, you'll get an email from the

quote-quality team asking you to write a note justifying why you chose a non-stimulant.

Adderall is used to treat ADHD. And it's a controlled substance. Its use is regulated by the government

because it's potentially addictive and prone to abuse. And the post suggested that Cerebral

was pressuring clinicians to prescribe it.

And I saw that and I thought that's interesting. I wonder if that's true. These are anonymous

reviews. You have to go verify them.

Over the next few months, Rolf teamed up with reporter Kadeja Safdar. Together, they found

former employees who had similar concerns about Cerebral.

I spoke to employees who cried on the phone because they were so stressed out that they

weren't treating patients properly about just having that on their conscience and then

...